Skip to Main Content

Paper Details

Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Blood
8
2021
CRM1, Choline salicylate, Chromosome region maintenance protein 1, DNA, K, KPT-330, Rad51, Salicylates, anticancer, blood cancers, cancer, diffuse large B-cell, hematological malignancies, lymphoma, malignant, malignant cells, mice, multiple myeloma, nonmalignant cells, poly (ADP-ribose), poly (ADP-ribose) polymerase, pyrimidine, salicylates, selinexor, thymidylate synthase

Datasets

Release 1.2